Lifescience, Health and Wellness Technologies: Future Growth Potential Revealed
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on development therapeutics for neurological disorders, mainly on drugs that target protein aggregates. A non-invasive brain computer interface (BCI) technology has also been discussed. Immunotherapeutics for cancer and other therapeutic indications have been highlighted with a focus on single domain and radiolabeled antibodies. Emerging therapeutic stra,tegies such as gene writing, and biomolecular condensates have also been discussed. A few innovations covering plant-based expression of recombinant proteins, protein purification, and protein stabilization have also been captured.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Take your first step towards achieving growth-centric solutions with our
Growth Pipeline Dialog™. Speak to our industry experts in a complimentary open discussion that will spark innovative thinking and growth opportunities that will benefit your organization.